The Filing Desk

DocGo vs Fulgent Genetics

DocGo DCGO · Fulgent Genetics FLGT · Health Care Services

Fulgent Genetics reported revenue of $323 million in fiscal 2025, about the same as DocGo's $322 million in fiscal 2025. DocGo's revenue fell 47.7% in its latest year, and Fulgent Genetics' grew 13.8%. DocGo had an operating margin of -55.3%, against -28.2% at Fulgent Genetics. Free cash flow was $30 million at DocGo and −$124 million at Fulgent Genetics.

Side by side

DocGoFulgent Genetics
Latest fiscal yearFY2025, Dec 31, 2025FY2025, Dec 31, 2025
Revenue$322M$323M
Revenue growth−47.7%13.8%
Revenue growth a year, last 5 years27.9%−5.2%
Gross margin—40.6%
Operating margin−55.3%−28.2%
Net margin−56.6%−18.8%
Free cash flow$30M−$124M
Free cash flow margin9.3%−38.5%
Return on capital−84.6%−8.7%
Net debt to EBITDA——
Dividends and buybacks$11M$11M
Change in diluted share count−9.5%1.8%
Last close$0.17$24.78
P/E at the last close——
Insider trades, last 12 monthssold $15,334sold $386,628
Piotroski F-score3 of 84 of 9
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.

Ten years

Revenue
US$ billions, fiscal years
DocGoFulgent Genetics
Operating margin
Percent of revenue
DocGoFulgent Genetics
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
DocGoFulgent Genetics

Start a new comparison

Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the DocGo and Fulgent Genetics pages.